Vibrio cholerae strain CVD103Hg.sup.r, method of making same, and vaccines derived therefrom
AssigneeThe University of Maryland System
InventorsJames B. Kaper, Myron M. Levine
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe University of Maryland System
InventorsJames B. Kaper, Myron M. Levine
Estimating the term…
Method of isolating deletion mutants of Vibrio cholerae, wherein the deletion is predetermined by digestion with restriction endonucleases of known specificity. The deletions are inserted into the Vibrio cholerae chromosome by in vivo recombination between a plasmid carrying the desired deletion, with adjacent flanking sequences, and the Vibrio cholerae chromosome. The invention includes the isolation and characterization of a new Vibrio cholerae strain, (ATCC No. 55456), having a deletion in the tox gene, as defined by Acc I, Xba I, Cla I and/or restriction endonuclease sites, and carrying a mercury resistance gene. The invention also includes vaccines for protecting against the symptoms of cholera as well as methods for achieving this protection.
Vibrio cholerae CVD103Hg.sup.r (ATCC No. 55456).
A culture of Vibrio cholerae comprising Vibrio cholerae CVD103Hg.sup.r (ATCC No. 55456).
A method of isolating deletion mutants of Vibrio cholerae Inaba comprising the steps of:
A Vibrio cholerae having substantially all of the identifying characteristics of CVD103Hg.sup.r (ATCC No. 55456).
Dependencies are inferred from the claim text.